10X Genomics (TXG) PT Lowered to $12 at UBS
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $61.54 -5.1%
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
UBS analyst John Sourbeer lowered the price target on 10X Genomics (NASDAQ: TXG) to $12.00 (from $14.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Jury finds Parse Biosciences willfully infringed 10x Genomics patents
- Nomura/Instinet Upgrades Malayan Banking Bhd (MAY:MK) to Buy
- Sunny Optical Technology Group Co Ltd (2382:HK) (SNPTF) PT Raised to HK$82.35 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
